BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 18772365)

  • 1. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.
    Tetri LH; Basaranoglu M; Brunt EM; Yerian LM; Neuschwander-Tetri BA
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G987-95. PubMed ID: 18772365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
    Kohli R; Kirby M; Xanthakos SA; Softic S; Feldstein AE; Saxena V; Tang PH; Miles L; Miles MV; Balistreri WF; Woods SC; Seeley RJ
    Hepatology; 2010 Sep; 52(3):934-44. PubMed ID: 20607689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.
    Neuschwander-Tetri BA; Ford DA; Acharya S; Gilkey G; Basaranoglu M; Tetri LH; Brunt EM
    Lipids; 2012 Oct; 47(10):941-50. PubMed ID: 22923371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
    Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
    Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source.
    Boland ML; Oró D; Tølbøl KS; Thrane ST; Nielsen JC; Cohen TS; Tabor DE; Fernandes F; Tovchigrechko A; Veidal SS; Warrener P; Sellman BR; Jelsing J; Feigh M; Vrang N; Trevaskis JL; Hansen HH
    World J Gastroenterol; 2019 Sep; 25(33):4904-4920. PubMed ID: 31543682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats.
    Jeyapal S; Putcha UK; Mullapudi VS; Ghosh S; Sakamuri A; Kona SR; Vadakattu SS; Madakasira C; Ibrahim A
    Eur J Nutr; 2018 Sep; 57(6):2171-2187. PubMed ID: 28676973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet.
    Koppe SW; Elias M; Moseley RH; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G378-84. PubMed ID: 19541924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content.
    Machado RM; Stefano JT; Oliveira CP; Mello ES; Ferreira FD; Nunes VS; de Lima VM; Quintão EC; Catanozi S; Nakandakare ER; Lottenberg AM
    J Nutr; 2010 Jun; 140(6):1127-32. PubMed ID: 20357081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease.
    Larner DP; Morgan SA; Gathercole LL; Doig CL; Guest P; Weston C; Hazeldine J; Tomlinson JW; Stewart PM; Lavery GG
    Endocrinology; 2016 Sep; 157(9):3493-504. PubMed ID: 27384305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.
    Collison KS; Maqbool Z; Saleh SM; Inglis A; Makhoul NJ; Bakheet R; Al-Johi M; Al-Rabiah R; Zaidi MZ; Al-Mohanna FA
    J Lipid Res; 2009 Aug; 50(8):1521-37. PubMed ID: 19001666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
    Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
    Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine.
    Panasevich MR; Meers GM; Linden MA; Booth FW; Perfield JW; Fritsche KL; Wankhade UD; Chintapalli SV; Shankar K; Ibdah JA; Rector RS
    Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E78-E92. PubMed ID: 28899857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.
    Dowman JK; Hopkins LJ; Reynolds GM; Nikolaou N; Armstrong MJ; Shaw JC; Houlihan DD; Lalor PF; Tomlinson JW; Hübscher SG; Newsome PN
    Am J Pathol; 2014 May; 184(5):1550-61. PubMed ID: 24650559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
    Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G762-72. PubMed ID: 22268099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.